American Tungsten and Antimony Ltd (ASX:AT4OD)
0.1200
+0.0100 (9.09%)
At close: Feb 10, 2026
ASX:AT4OD Revenue
In the fiscal year ending June 30, 2025, American Tungsten and Antimony had annual revenue of 27.98K AUD with 4,178.13% growth. American Tungsten and Antimony had revenue of -1.25K in the half year ending June 30, 2025.
Revenue
27.98K
Revenue Growth
+4,178.13%
P/S Ratio
7,213.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
201.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 27.98K | 27.33K | 4,178.13% |
| Jun 30, 2024 | 654.00 | -8.11K | -92.53% |
| Jun 30, 2023 | 8.76K | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alliance Aviation Services | 773.08M |
| Apiam Animal Health | 206.92M |
| MC Mining | 26.62M |
| Recce Pharmaceuticals | 7.51M |
| EMVision Medical Devices | 5.05M |
| Alligator Energy | 1.11M |
| Epiminder | 445.18K |
| KGL Resources | 252.96K |